Baxter International Inc. Stock
Equities
BAX
US0718131099
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
41.02 USD | +1.53% | +3.66% | +6.10% |
05:25pm | Edwards Lifesciences Corporation: The story continues | |
Apr. 15 | Exact Sciences Names Aaron Bloomer CFO | MT |
Financials (USD)
Sales 2024 * | 15.11B | Sales 2025 * | 15.68B | Capitalization | 20.58B |
---|---|---|---|---|---|
Net income 2024 * | 747M | Net income 2025 * | 960M | EV / Sales 2024 * | 1.97 x |
Net Debt 2024 * | 9.15B | Net Debt 2025 * | 8.02B | EV / Sales 2025 * | 1.82 x |
P/E ratio 2024 * |
21.5
x | P/E ratio 2025 * |
17.9
x | Employees | 60,000 |
Yield 2024 * |
2.86% | Yield 2025 * |
3.09% | Free-Float | 74.06% |
Latest transcript on Baxter International Inc.
1 day | +1.16% | ||
1 week | +3.18% | ||
Current month | -4.47% | ||
1 month | -2.30% | ||
3 months | +6.27% | ||
6 months | +24.29% | ||
Current year | +5.61% |
Managers | Title | Age | Since |
---|---|---|---|
Joe Almeida
CEO | Chief Executive Officer | 61 | 15-09-30 |
Joel Grade
DFI | Director of Finance/CFO | 54 | 23-10-17 |
Reaz Rasul
CTO | Chief Tech/Sci/R&D Officer | - | 16-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Stephen Oesterle
BRD | Director/Board Member | 73 | 17-02-05 |
Peter Wilver
BRD | Director/Board Member | 64 | 22-05-09 |
Director/Board Member | 64 | 19-02-17 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
13.07% | 215 M€ | +11.65% | - | |
1.23% | 18 M€ | +2.56% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-23 | 41.02 | +1.53% | 2 636 501 |
24-04-22 | 40.4 | +2.36% | 3,272,883 |
24-04-19 | 39.47 | -0.45% | 2,808,386 |
24-04-18 | 39.65 | +0.33% | 2,332,137 |
24-04-17 | 39.52 | -0.13% | 2,809,448 |
Delayed Quote Nyse, April 23, 2024 at 11:15 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.61% | 20.58B | |
-2.26% | 186B | |
-1.83% | 107B | |
-3.67% | 67.57B | |
+8.37% | 50.7B | |
+15.92% | 47.2B | |
-0.45% | 39.72B | |
+9.74% | 27.48B | |
+2.13% | 25.65B | |
+13.37% | 24.97B |
- Stock Market
- Equities
- BAX Stock